Zobrazeno 1 - 10
of 40
pro vyhledávání: '"N Vicente Oliveros"'
Autor:
M Rodríguez Marín, E Delgado-Silveira, E Mora-Rivas, LE Montes-Jovellar-Gonzalez, M Muñoz-Garcia, N Vicente-Oliveros, C Palomar-Fernandez, AM Alvarez Diaz
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40aa2349d8684e9f17fb8b1794842fe1
https://doi.org/10.1136/ejhpharm-2023-eahp.113
https://doi.org/10.1136/ejhpharm-2023-eahp.113
Autor:
M. Vélez-Díaz-Pallarés, E. Delgado Silveira, A.M. Álvarez Díaz, C. Pérez Menéndez-Conde, N. Vicente Oliveros, T. Bermejo Vicedo
Publikováno v:
Neurología (English Edition), Vol 27, Iss 1, Pp 34-38 (2012)
Introduction: Published data demonstrate a serious interaction between valproic acid and meropenem. However, recommendations about the management of concomitant treatment are contradictory; some experts recommend closer monitoring of valproic acid se
Externí odkaz:
https://doaj.org/article/a53008fb9a80485ba545df12a538482d
Autor:
M. Vélez Díaz-Pallarés, E. Delgado Silveira, A.M. Álvarez Díaz, C. Pérez Menéndez-Conde, N. Vicente Oliveros, T. Bermejo Vicedo
Publikováno v:
Neurología, Vol 27, Iss 1, Pp 34-38 (2012)
Resumen: Introducción: Existen referencias en la literatura acerca de la gravedad de la interacción entre el ácido valproico y el meropenem. Sin embargo, las recomendaciones en cuanto a su manejo son contradictorias, recomendándose en algunos est
Externí odkaz:
https://doaj.org/article/85a9441a098e4b6cb42be740bb23c5a4
Autor:
MT Bermejo Vicedo, Má Rodríguez Sagrado, L Quesada-Muñoz, M Rodríguez Marín, M. Vélez-Díaz-Pallarés, N Vicente Oliveros, S Sanz Merino, B Montero Llorente, T Gramage Caro
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Recently, change from cobicistat to ritonavir is being promoted at a tertiary hospital for economic reasons. Therefore, there is a growing need to study what this switch may involve. Aim and objectives Our objective was to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::041fd0b37106343365c184f4323bed28
https://doi.org/10.1136/ejhpharm-2020-eahpconf.167
https://doi.org/10.1136/ejhpharm-2020-eahpconf.167
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M. Vélez-Díaz-Pallarés, N Vicente Oliveros, MJ Vivancos Gallego, A Moreno Zamora, T Gramage Caro, Má Rodríguez Sagrado, M Salgado Del Valle, T. Bermejo Vicedo, B Montero Llorente, Z Santander Sánchez
Publikováno v:
Section 6: Education and Research.
Background Tenofovir alafenamide (TAF) is associated with less renal and bone toxicity compared with tenofovir disoproxil (TDF) but with elevation of cholesterol levels. In our hospital, patients were automatically changed from a regimen with Evipler
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::afd8e66e50bce0b15dd22ab1cff72cd4
https://doi.org/10.1136/ejhpharm-2019-eahpconf.606
https://doi.org/10.1136/ejhpharm-2019-eahpconf.606
Autor:
T Gramage Caro, N Vicente Oliveros, C. Pérez Menéndez-Conde, T. Bermejo Vicedo, E. Delgado Silveira, AMAlvarez Díaz
Publikováno v:
Patient safety and risk management.
Background New technology can improve patient safety but also has the potential to introduce new errors and risks into healthcare delivery Purpose To evaluate the effect of an electronic medication administration record (eMAR) application on the rate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d34cf2f04c2c3b6119e7ed29a63b40e
https://doi.org/10.1136/ejhpharm-2017-000640.580
https://doi.org/10.1136/ejhpharm-2017-000640.580
Autor:
C Palomar Fernández, C. Pueyo López, A Molina Ruano, N Vicente Oliveros, AM Rojo Sanchis, T. Bermejo Vicedo
Publikováno v:
Clinical pharmacy.
Background Medication costs are increasing, and hospital budgets are small. Clinical trials are an alternative for medication cost savings. Purpose To assess the savings for medication by inclusion of patients in myeloma multiple (MM) clinical trials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b93d808be2cd43f81614e2d02aa0de3
https://doi.org/10.1136/ejhpharm-2017-000640.92
https://doi.org/10.1136/ejhpharm-2017-000640.92
Autor:
E. Delgado-Silveira, T. Bermejo-Vicedo, N. Vicente-Oliveros, A M Álvarez-Díaz, C. Pérez-Menéndez-Conde, M. Vélez-Díaz-Pallarés
Publikováno v:
Revista de Calidad Asistencial. 29:17-21
Resumen Objetivo Analizar el impacto de las alertas interactivas modales en la incidencia de la prescripcion concomitante de acido valproico (AVP) y meropenem. Material y metodo Estudio analitico de intervencion desarrollado en un hospital de tercer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::543643324f354d69a0c66de98fb157f7
https://doi.org/10.1016/j.cali.2013.07.005
https://doi.org/10.1016/j.cali.2013.07.005
Autor:
A.M. Álvarez Díaz, M. Vélez-Díaz-Pallarés, N Vicente Oliveros, E. Delgado Silveira, C. Pérez Menéndez-Conde, T. Bermejo Vicedo
Publikováno v:
Neurología (English Edition), Vol 27, Iss 1, Pp 34-38 (2012)
Introduction: Published data demonstrate a serious interaction between valproic acid and meropenem. However, recommendations about the management of concomitant treatment are contradictory; some experts recommend closer monitoring of valproic acid se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1ef51241f5576d1ef3afef3948ee653
http://www.sciencedirect.com/science/article/pii/S2173580812000107
http://www.sciencedirect.com/science/article/pii/S2173580812000107